Kailera Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 12.67 USD (Oct 30, 2026, 2:47 PM EDT) · Market cap 1.64B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.
Details
| Name | Kailera Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 145 |
| Founded | 2024 |
| Ipo Date | 2026-04-17 |
| Ceo | Ronald Renaud |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US4829311020 |
| Cusip | 482931102 |
| Cik | 2096997 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Ronald C. Renaud Jr., M.B.A. | President, Chief Executive Officer and Director |
| Paul Douglas Burgess J.D., M.S. | Chief Operating and Business Officer |
| Jamie Beth Coleman | Chief Commercial Officer |
| Douglas W. Pagan M.B.A. | Chief Financial Officer |
| Maura Gavaghan | Vice President of Corporate Communications and Investor Relations |
| Scott M. Akamine J.D. | Chief Legal Officer and Secretary |
| Paula A. Cloghessy SHRM-SCP, SPHR | Chief People Officer |
| Dr. Scott M. Wasserman M.D. | Chief Medical Officer |
| Kathleen Tregoning M.A. | Chief Corporate Affairs Officer |
| Corey Manchester | Treasurer |
Contact
| Address | 180 Third Avenue, 4th Floor, Waltham, Massachusetts 02451, United States |
| Phone | 781 317 0290 |
| Website | https://www.kailera.com |